Ribociclib acetate
Ribociclib acetate is a degradation product of Ribociclib under acid-base hydrolysis conditions. Ribociclib acetate has been predicted to be carcinogenic[1].
Product Specifications
CAS Number
2762182-61-4
UNSPSC
12352005
Target
Drug Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ribociclib-acetate.html
Solubility
DMSO : 4 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC2=C(N1C3CCCC3)N=C(NC4=NC=C(N5CCNCC5)C=C4)N=C2)O
Molecular Formula
C21H25N7O2
Molecular Weight
407.47
References & Citations
[1]Sahu AK, et al. Identification and structural characterization of potential degraded impurities of ribociclib by time of flight -tandem mass spectrometry, and their toxicity prediction. J Pharm Biomed Anal. 2021 Apr 15;197:113933.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
26208121 3x 1.0µg DNA
KRTAP6-2 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details NSL0226Ch 96 Tests
Chicken soluble receptor activator ofnuclear factor-kB ligand (sRANKL) ELISA Kit
Sign In for Pricing
View Details